Related Experiment Video
Updated: Feb 4, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Molecular docking analysis of phytoconstituents from Nilavaagai Chooranam with histamine H1 receptor
Vinu Bharathi Balasubramaniam1, Vinodini Ramamoorthy1, Saraswathi Balasubramanian2
1Department of Clinical Research, Siddha Regional Research Institute, Central Council Research in Siddha, Ministry of Ayush, Government of India, Kuyavarpalayam, Puducherry, India.
Abstract:
Nilavaagai Chooranam, a polyherbal formulation in Siddha medicine, is traditionally used for treating respiratory and allergic conditions. Histamine H1 receptors are central to allergic reactions and modulating their activity can help manage conditions like allergic rhinitis and asthma. The objective of this study is to investigate the potential of bioactive compounds in Nilavaagai Chooranam to modulate histamine-mediated allergic responses by targeting the histamine H1 receptor. Molecular docking analysis was conducted to evaluate the binding affinities of key phytochemicals Kaempferol, Gingerenone-A, Piperic acid, Embelin, Carvone, and β-pinene against the H1 receptor (PDB ID: 3RZE). Cetirizine, a well-known H1 antagonist, was used as a reference ligand. Significant interactions were observed between the phytochemicals and the H1 receptor. Gingerenone-A and Embelin exhibited the highest binding affinities, with interactions involving key residues like Trp428, Tyr431, and Phe432. These results were comparable to those of Cetirizine. Data shows that Nilavaagai Chooranam contains compounds with anti-allergic and anti-inflammatory potential, supporting its traditional use in treating histamine-mediated conditions. Further in vitro and in vivo studies are needed to validate these in silico results and explore the formulation's potential as a natural alternative to synthetic antihistamines.
More Related Videos
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Internal Receptors
Molecular Models
Molecular Orbital Theory II
Receptor-mediated Endocytosis
Molecular Orbital Theory I